Friday May 18 | Wall St. Cheat Sheet
Healthcare Business Recap: Dendreon Attack Continues, Pfizer Recall
The FDA grants final approval to Perrigo's abbreviated new drug application for Lansoprazole capsules for the treatment of frequent reflux, and shipments to customers began immediately.
IntegenX Names Biotechnology Veteran David V. Smith Chief Operating Officer
PLEASANTON, Calif. -- -- IntegenX Inc., a privately held company and leading developer of rapid human DNA identification technology, DNA sequencing library preparation systems, and DNA/RNA room temperature stability and storage products, today announced the appointment of David V. Smith as Chief Operating Officer.
Healthcare Business Recap: Possible Dividend Boosts, Hospira Slides
Shares of Ventrus Biosciences pop, subsequent to the announcement that Phase III trials of its Diltiazem treatment for the relief of pain associated with anal fissures showed significant improvements over placebos.